FDA: Opioid Overdose & Death Risks Highlighted in Labels
FDA’s Opioid Labeling Overhaul: A New Chapter in the Fight Against Addiction The Food and Drug Administration’s (FDA) recent decision to strengthen opioid labeling is a significant step in addressing the ongoing opioid crisis. This move mandates that manufacturers highlight the risks associated with higher doses and long-term use. But what does this mean for … Read more